Sharemaestro company-news research for Starpharma Holdings Limited (SPL), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
ASX
Australia
Measured evidence
Company news sentiment
SPL news sentiment
Starpharma Holdings Limited
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone50Neutral is 50
Balanced news tone
31/100 evidence confidence
100% direct company focus
1 current stories across 1 publishers
Current company news
Price moving ahead of tone
Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.
Latest source headline UBS Group AG Ceases Substantial Shareholding in StarPharma Holdings Limited Kalkine · 21 Jul 2026 07:00What supports the read
1 current stories are mapped specifically to SPL.
What tempers the read
Only 1 publisher currently contribute to the measured read.
Price is moving more forcefully than the current news tone suggests.
Evidence confidence is 31/100, below the threshold for a firm classification.
50/100
Weighted toneBalanced news tone
31/100
Evidence confidencethin evidence
100%/100
Company focus1 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
No measurable trajectory yet
The chart will begin when a dated headline passes the relevance and freshness controls.
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth12
1.0 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness2
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Price is moving more forcefully than the current news tone suggests.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
News subjects
What is shaping the score
Market update501 stories · 100%
Source mix
Where the evidence comes from
Kalkine501 stories · 100%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#150Tone
KalkineDirect company coverage
UBS Group AG Ceases Substantial Shareholding in StarPharma Holdings Limited
- Published
- 21 Jul 2026 07:00
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
SPL news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
The archive is starting now
Each successful collection will retain its qualifying headlines here instead of replacing the previous set.
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.